Miravant Medical Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRVT research report →
Price Chart
About the company
Miravant Medical Technologies Inc. operates as a specialized firm dedicated to pharmaceutical research and development. A cornerstone of its work involves PhotoPoint, an innovative photodynamic therapy designed to eradicate cancerous cells when exposed to light.
- CEO
- David E. Mai
- IPO
- 1995
- Employees
- 47
- HQ
- Santa Barbara, CA, US
Get TickerSpark's AI analysis on MRVT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $113.57K
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.05
- EV/EBITDA
- -0.37
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 352.89%
- ROIC
- 180.96%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $13.05M
- Net Income
- $-15,896,000-112.9%
- EPS
- $-0.48-60.0%
- OCF Growth
- -6.5%
- FCF Growth
- -3.5%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -7.25
- RSI (14)
- 42
- Avg Volume
- 44
No earnings-call transcripts are available for MRVT yet.
- Free Float
- 99.9%
- Shares Outstanding
- 37.86M
- Float Shares
- 37.82M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 05 | Sutcliffe Robert J | other | 10,000 |
| Jul 7, 05 | Sutcliffe Robert J | other | 100,000 |
| Jan 27, 06 | Sutcliffe Robert J | other | 40,000 |
| Jan 27, 05 | PHILPOTT JOHN M | other | 50,393 |
| Jun 21, 04 | EDELMAN JOSEPH | sell | 25,500 |
| Jun 21, 04 | EDELMAN JOSEPH | sell | 2,500 |
| Jun 17, 04 | EDELMAN JOSEPH | sell | 10,000 |
| Jun 16, 04 | EDELMAN JOSEPH | sell | 49,500 |
| Jun 17, 04 | EDELMAN JOSEPH | sell | 22,500 |
| Jun 18, 04 | EDELMAN JOSEPH | sell | 22,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MRVT coverage
Recent articles, reports, and earnings notes.
No research on MRVT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRVT report →